托法替尼杂质01对照品

(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺盐酸盐;顺式-1-苄基-4-甲基-3-甲氨基-哌啶双盐酸盐;顺式-1-苄基-4-甲基-3-甲氨基-哌啶双盐酸盐(托法替尼中间体);(3R,4R)-N-苄基-3-甲氨基-4-甲基哌啶双盐酸盐;(3R,4R)-1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐;7-氰基吲哚啉;CIS-N-苄基-3-甲氨基-4-甲基哌啶双盐酸盐;N,N-二苄基乙醇胺;顺-1-苄基-N,4-二甲基哌啶-3-胺二盐酸盐;顺式-（3R,4R）-1-苄基-4-甲基-3-甲氨基-哌啶双盐酸盐;顺式1-苄基-4-甲基-3-甲氨基-哌啶盐酸盐;托法替尼杂质01;托法替尼中间体 A;托法替尼 INTA5;托法替尼TOFACITINIB中间体;(3R,4R)-1-苄基-N,4-二甲基哌啶-3-胺盐酸盐;(3R,4R)-1-苄基-4-甲基-3-甲氨基哌啶双盐酸盐

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;cis-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;cis-1-Benzyl-N3,4-dimethylpiperidin-3-amine dihydrochloride;(3R,4R)-1-benzyl-N,4-diMethylpiperidin-3-aMine BIS-(HYDROCHLORIDE);(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride;(3R,4R)- cis-1-Benzyl-4-Methyl-3-(MethylaMino)piperidine dihydrochloride;cis-1-Benzyl-3-(methylamino)-4-methylpiperidine Dihydrochloride;CIS-N-BENZYL-3-METHYLAMINO-4-METHYL-PIPERIDINE BIS-(HYDROCHLORIDE);Tofacitinib interMediate A;Tofacitinib intermediate 3;(3R,4R)-N,4-DiMethyl-1-(phenylMethyl)-3-piperidi;(3R,4R)- Cis-1-benzyl-4-Methyl-3-(MethylaMino)piperidine;(3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine HCl;(3R,4R)-1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORID;(3R,4R)-rel-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride;(3R,4R)-(1-Benzyl-4-methyl-piperidin-3-yl)-methyl-amine dihydrochloride;3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride(1:2),(3R,4R)-;(1-Benzyl-4-methyl-piperidin-3-yl)-methyl-amine dihydrochloride

1062580-52-2

C₁₄H₂₄Cl₂N₂

291.26